• Info▾
    • About NordiQC
    • Organization
    • Subscription
    • Invoice & payment
    • News
    • Contact
    • New participant
    • Accompanying letters
    • Questions (FAQ)
    • ISO accreditation
    • References
  • Modules▾
    • Current modules
    • Future modules
  • Assessments
  • Protocols
  • Controls
  • Events▾
    • Overview
    • Workshop
  • Login
2024
02
Oct
NordiQC Workshop in Diagnostic Immunohistochemistry 2024
Aalborg, Denmark - 2–4 Oct
2023
04
Oct
NordiQC Workshop in Diagnostic Immunohistochemistry 2023
Aalborg, Denmark - 4–6 Oct
17
Apr
Academy of Immunohistochemistry
Krakow, Poland - 17–19 Apr
2022
05
Oct
NordiQC Workshop in Diagnostic Immunohistochemistry 2022
Aalborg, Denmark - 5–7 Oct
1-1 SN Welcome
1-2 SN Pre-analytical phase
1-3/1-4 MB Analytical phase I & II
1-5 SN Tissue tool box for controls
1-6 DVH Validation and verification process for IHC
2-1 RR The unknown primary tumour
2-2 TJ Antibody selection, protocols and controls
2-3 SH Hematolymphoid neoplasms - IHC for diagnostic use
2-4 TJ Antibody selection, protocols and controls
2-5 AVL Breast cancer - IHC for diagnostic use
2-6 HLK Antibody selection, protocols and controls
2-7 HH Lung cancer - IHC for diagnostic use
2-8 HLK Antibody selection, protocols and controls
2-9 SN The antibody graveyard
3-1 ISK Immunocytochemistry - overview, considerations and applications
3-2 MB IHC double stains
3-3 SN IHC stainers - overview, pros and cons
3-4 HH IHC in the time of molecular era
3-5 MB In situ hybridization
Programme
© NordiQC 2023